Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium)

J Pharm Pharmacol. 2001 Nov;53(11):1515-23. doi: 10.1211/0022357011777882.

Abstract

The activity of CVT-E002, an aqueous extract containing mainly oligosaccharides and polysaccharides from North American ginseng (Panax quinquefolium), as an immunobooster on murine spleen cells and peritoneal macrophages, was studied in-vitro. CVT-E002 stimulated the proliferation of normal mouse spleen cells, of which the major responding subpopulation was identified as B lymphocytes. CVT-E002 also activated peritoneal exudate macrophages leading to enhanced interleukin-1 (IL-1), interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-alpha) and nitric oxide (NO) production. In addition, CVT-E002 stimulated in-vivo immunoglobulin G (IgG) production in treated mice. These results identify some of the immunomodulating activities of CVT-E002 and suggest its use clinically for the modulation of immune responses.

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • Cell Division / drug effects
  • Dose-Response Relationship, Drug
  • Immunity, Innate / drug effects
  • Immunoglobulin G / blood
  • Immunoglobulin G / drug effects
  • Interleukin-1 / metabolism
  • Interleukin-6 / metabolism
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Nitric Oxide / metabolism
  • Panax / chemistry*
  • Plant Extracts / pharmacology*
  • Spleen / cytology
  • Spleen / drug effects
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Adjuvants, Immunologic
  • Immunoglobulin G
  • Interleukin-1
  • Interleukin-6
  • Plant Extracts
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide